Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Broker's Calls

Analysts upbeat on Ascendas REIT amid improved occupancy in 3Q

Jeffrey Tan
Jeffrey Tan • 2 min read
Analysts upbeat on Ascendas REIT amid improved occupancy in 3Q
CGS-CIMB Research has upgraded AREIT to an “add” rating from “hold” and raised its target price to $3.20 from $3.12, previously.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

As Ascendas REIT (AREIT) has delivered better occupancy of 91.9% in 3QFY2020, analysts are positive on its prospects ahead.

CGS-CIMB Research has upgraded AREIT to an “add” rating from “hold” and raised its target price to $3.20 from $3.12, previously.

The brokerage has also increased its FY2021-2022 distribution per unit (DPU) forecasts to factor in interest cost savings from the perpetual securities issued in September.

The higher forecasts also account for the new contributions from AREIT’s two Australian properties under development, scheduled to be completed over the next two years.

“AREIT’s share price had retraced by 13% over the past three months and offers attractive FY21 yield of 5.1%,” CGS-CIMB analysts Lock Mun Yee and Eing Kar Mei write in an Oct 26 report.

Meanwhile, Maybank Kim Eng has maintained its “buy” call for AREIT with an unchanged target price of $4.00.

See also: The year's most resilient REITs

It has also kept its earnings forecasts as it believes the drivers of AREIT’s bottom line are intact.

“Fundamentals remain strong, supported by scale, concentrated Singapore business parks portfolio, and DPU upside from further overseas diversification,” Maybank KE analyst Chua Su Tye writes in a note dated Oct 27.

OCBC Investment Research has also retained its “buy” recommendation for AREIT with an unchanged fair value of $3.92.

The brokerage deems AREIT’s attractive distribution yield of 5.1% for FY20 and 5.4% for FY21 as a “good entry point”.

“We also see upside potential from inorganic growth opportunities ahead given AREIT’s healthy balance sheet and geographical reach,” the OCBC research team writes in an Oct 27 report.

As at 11.56 am, AREIT was up 4 cents or 1.3% at $3.07 with 5.6 million units changed hands.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.